Praluzatamab Ravtansine Uses, Dosage, Side Effects and more
Praluzatamab Ravtansine is under investigation in clinical trial NCT03149549 (PROCLAIM-Praluzatamab Ravtansine: A Trial to Find Safe and Active Doses of an Investigational Drug Praluzatamab Ravtansine for Patients With Selected Solid Tumors).
| Trade Name | Praluzatamab Ravtansine |
| Generic | CX-2009 |
| CX-2009 Other Names | Anti-cd166 probody-drug conjugate cx-2009, Praluzatamab ravtansine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
